AU2292400A - Novel compounds - Google Patents

Novel compounds

Info

Publication number
AU2292400A
AU2292400A AU22924/00A AU2292400A AU2292400A AU 2292400 A AU2292400 A AU 2292400A AU 22924/00 A AU22924/00 A AU 22924/00A AU 2292400 A AU2292400 A AU 2292400A AU 2292400 A AU2292400 A AU 2292400A
Authority
AU
Australia
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22924/00A
Inventor
Carlota Vinals Bassols
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9901078.7A external-priority patent/GB9901078D0/en
Priority claimed from GBGB9902090.1A external-priority patent/GB9902090D0/en
Priority claimed from GBGB9902169.3A external-priority patent/GB9902169D0/en
Priority claimed from GBGB9902168.5A external-priority patent/GB9902168D0/en
Priority claimed from GBGB9902163.6A external-priority patent/GB9902163D0/en
Priority claimed from GBGB9907901.4A external-priority patent/GB9907901D0/en
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Publication of AU2292400A publication Critical patent/AU2292400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU22924/00A 1999-01-19 2000-01-17 Novel compounds Abandoned AU2292400A (en)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
GBGB9901078.7A GB9901078D0 (en) 1999-01-19 1999-01-19 Novel compounds
GB9901078 1999-01-19
GBGB9902090.1A GB9902090D0 (en) 1999-01-29 1999-01-29 Novel compounds
GB9902090 1999-01-29
GBGB9902169.3A GB9902169D0 (en) 1999-02-01 1999-02-01 Novel compounds
GBGB9902168.5A GB9902168D0 (en) 1999-02-01 1999-02-01 Novel compounds
GB9902168 1999-02-01
GB9902163 1999-02-01
GB9902169 1999-02-01
GBGB9902163.6A GB9902163D0 (en) 1999-02-01 1999-02-01 Novel compounds
GBGB9907901.4A GB9907901D0 (en) 1999-04-07 1999-04-07 Novel compounds
GB9907901 1999-04-07
PCT/EP2000/000346 WO2000043509A2 (en) 1999-01-19 2000-01-17 Polynucleotides and their applications in diagnostics

Publications (1)

Publication Number Publication Date
AU2292400A true AU2292400A (en) 2000-08-07

Family

ID=27547331

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22924/00A Abandoned AU2292400A (en) 1999-01-19 2000-01-17 Novel compounds

Country Status (5)

Country Link
EP (1) EP1144622A2 (en)
JP (1) JP2002534977A (en)
AU (1) AU2292400A (en)
CA (1) CA2358697A1 (en)
WO (1) WO2000043509A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006200916B2 (en) * 2000-06-21 2009-02-05 Amgen Inc. Secreted Epithelial Colon Stromal-1 Polypeptides, Nucleic Acids Encoding the Same and Uses Thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995015381A2 (en) * 1993-12-02 1995-06-08 The Johns Hopkins University HUMAN MUTATOR GENE hMSH2 AND HEREDITARY NON POLYPOSIS COLORECTAL CANCER
WO1997033903A1 (en) * 1996-03-11 1997-09-18 Human Genome Sciences, Inc. HUMAN MutY
AU7499198A (en) * 1997-05-21 1998-12-11 Johns Hopkins University, The Gene expression profiles in normal and cancer cells

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006200916B2 (en) * 2000-06-21 2009-02-05 Amgen Inc. Secreted Epithelial Colon Stromal-1 Polypeptides, Nucleic Acids Encoding the Same and Uses Thereof

Also Published As

Publication number Publication date
WO2000043509A2 (en) 2000-07-27
CA2358697A1 (en) 2000-07-27
JP2002534977A (en) 2002-10-22
EP1144622A2 (en) 2001-10-17
WO2000043509A3 (en) 2000-11-02

Similar Documents

Publication Publication Date Title
AU1278701A (en) Novel compounds
AU5546000A (en) Compounds
AU2001271434A1 (en) Novel skateboard-bicycle combination
AU4260199A (en) Novel compounds
AU2408300A (en) Novel compounds
AUPP999799A0 (en) New compound
AU2014800A (en) Novel compounds
AU1746401A (en) Compounds
AUPQ441499A0 (en) Novel compound
AU6032100A (en) New compounds
AU3997700A (en) Anti-first-pass effect compounds
AU4132200A (en) Novel compounds
AU2359301A (en) Novel ss-defensins
AU2109700A (en) Novel compounds
AU2187799A (en) Novel taxaneterpine compounds
AU5787901A (en) Compound
AU6567400A (en) Substituted 2-imino-thiazolines
AU2288900A (en) Novel compounds
AU5119400A (en) Compounds
AU4156800A (en) Novel compounds
AU7784700A (en) Novel compounds
AU1385701A (en) Novel compounds
AU6168900A (en) Compounds
AU2668000A (en) Bis-styrylbiphenyl compounds
AU2985200A (en) Novel sialoadhesins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase